Skip to main content

Table 4 Bivariate Analysis Association between SIBO and Significant Steatosis

From: The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience

Variables Significant Steatosis Total (%) p value PR CI 95%
Yes No
SIBO, n (%)
 Yes 23 (63.9) 13 (36.1) 36 (100) 0.951 1.026 0.452–2.329
 No 50 (63.3) 29 (36.7) 79 (100)    
  1. SIBO Small Intestinal Bacterial Overgrowth, PR Prevalence Ratio, CI Confidence Interval